What is The Pathology Group?
Based in Oklahoma City, The Pathology Group, P.C. operates as a physician-owned collective of board-certified pathologists. With a legacy spanning over four decades, the firm provides comprehensive anatomic, clinical, and hematopathology services. By integrating 24/7 pathologist availability with advanced EMR access, the group ensures rapid, accurate diagnostic interpretations. Their market position is defined by a commitment to patient-centered care and reliable testing consultations, serving as a critical diagnostic partner for healthcare providers throughout the region.
The organization distinguishes itself through a model that prioritizes physician oversight and high-quality diagnostic precision. By maintaining a focus on personalized support and second-opinion interpretations, The Pathology Group has established itself as a cornerstone of the Oklahoma medical community, bridging the gap between complex laboratory analysis and actionable clinical outcomes.
How much funding has The Pathology Group raised?
The Pathology Group has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in The Pathology Group
PPP
Public-Private Partnership
What's next for The Pathology Group?
With the recent capital deployment, The Pathology Group is well-positioned to scale its diagnostic capabilities and modernize its technological framework. The strategic focus will likely shift toward optimizing laboratory throughput and expanding the reach of its specialized pathology services. As the firm navigates the complexities of the modern healthcare environment, this late-stage financing provides the necessary liquidity to pursue operational efficiencies and potentially broaden its service offerings. The organization remains committed to its core mission of delivering high-quality, physician-led diagnostics while adapting to the evolving demands of the clinical landscape.
See full The Pathology Group company page
